HUTCHMED (China) (HCM) Common Equity (2016 - 2025)
HUTCHMED (China) (HCM) has disclosed Common Equity for 12 consecutive years, with $1.3 billion as the latest value for Q4 2025.
- On a quarterly basis, Common Equity rose 64.66% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 64.66% increase, with the full-year FY2025 number at $1.3 billion, up 64.66% from a year prior.
- Common Equity was $1.3 billion for Q4 2025 at HUTCHMED (China), up from $759.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.3 billion in Q4 2025 to a low of $636.9 million in Q4 2022.
- A 5-year average of $886.2 million and a median of $759.9 million in 2024 define the central range for Common Equity.
- Peak YoY movement for Common Equity: skyrocketed 100.31% in 2021, then plummeted 38.73% in 2022.
- HUTCHMED (China)'s Common Equity stood at $1.0 billion in 2021, then plummeted by 38.73% to $636.9 million in 2022, then increased by 16.73% to $743.4 million in 2023, then rose by 2.23% to $759.9 million in 2024, then surged by 64.66% to $1.3 billion in 2025.
- Per Business Quant, the three most recent readings for HCM's Common Equity are $1.3 billion (Q4 2025), $759.9 million (Q4 2024), and $743.4 million (Q4 2023).